Elevance Health Inc.ELVNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +6.55% | +14.83% | +14.04% | +12.33% | +9.47% |
| Gross Profit Growth | +5.56% | +12.87% | -0.03% | +3.07% | -2.18% |
| EBITDA Growth | -20.19% | -0.59% | -16.33% | +7.09% | -26.56% |
| Operating Income Growth | -24.92% | -1.97% | -12.99% | +2.63% | -38.58% |
| Net Income Growth | -51.17% | -2.80% | -24.22% | +17.03% | +30.86% |
| EPS Growth | -49.86% | -0.10% | -22.10% | +22.02% | +34.24% |
| EPS Diluted Growth | -50.14% | +0.21% | -21.62% | +22.02% | +36.46% |
| Weighted Average Shares Growth | -2.40% | -2.71% | -2.76% | -3.10% | -2.50% |
| Weighted Average Shares Diluted Growth | -1.99% | -2.99% | -3.26% | -3.13% | -4.02% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -48.58% | +359.51% | -57.60% | -88.10% |
| Free Cash Flow Growth | +0.00% | -51.68% | +1341.13% | -66.95% | -154.43% |
| Receivables Growth | +4.78% | +18.46% | +19.36% | +18.74% | +16.70% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +7.31% | +6.99% | +7.92% | +5.33% | +3.94% |
| Book Value per Share Growth | +7.69% | +7.58% | +6.57% | +3.62% | +8.93% |
| Debt Growth | +22.69% | +13.43% | +9.03% | +18.25% | +1.63% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |